Published in Blood on April 15, 1991
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (2001) 2.87
Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.61
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci U S A (1993) 1.24
Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med (1993) 1.19
Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest (1992) 1.12
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer. Br J Pharmacol (1996) 0.98
Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial. PLoS One (2013) 0.98
Tat-independent replication of human immunodeficiency viruses. J Clin Invest (1995) 0.95
Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. J Virol (1997) 0.91
Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol Med (1994) 0.86
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro. Clin Exp Immunol (2000) 0.81
Compounds that target novel cellular components involved in HIV-1 transcription. Mol Med (1995) 0.80
Inhibition of tumor necrosis factor alpha alters resistance to Mycobacterium avium complex infection in mice. Antimicrob Agents Chemother (1998) 0.78
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors. Biology (Basel) (2012) 0.78
Pentoxifylline in treatment of acquired immunodeficiency syndrome? Blood (1992) 0.75
Effects of pentoxifylline on equine neutrophil function and flow properties. Can J Vet Res (1992) 0.75
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (1992) 24.32
Penicillin-binding proteins and cell shape in E. coli. Nature (1975) 10.20
A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A (1974) 8.74
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell (1984) 6.53
Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med (1995) 6.50
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science (1995) 6.30
Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res (1993) 5.82
Animal cell cycle. Annu Rev Biochem (1978) 4.80
DNA synthesis inhibition and the induction of protein X in Escherichia coli. J Mol Biol (1976) 4.65
Membrane transport proteins. Proteins that appear to be parts of membrane transport systems are being isolated and characterized. Science (1968) 4.23
Cytidine triphosphate synthetase of Escherichia coli B. I. Purification and kinetics. J Biol Chem (1967) 4.01
Transport changes rapidly initiated by serum addition to "contact inhibited" 3T3 cells. Proc Natl Acad Sci U S A (1969) 3.98
Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med (1999) 3.86
Changes of membrane proteins and their relation to deoxyribonucleic acid synthesis and cell division of Escherichia coli. J Biol Chem (1970) 3.76
Multiple pathways of putrescine biosynthesis in Escherichia coli. J Biol Chem (1966) 3.74
Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid. J Bacteriol (1975) 3.49
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science (1995) 3.46
Model for regulation of Escherichia coli DNA repair functions. Proc Natl Acad Sci U S A (1975) 3.32
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res (1991) 3.24
Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res (1992) 3.12
Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci U S A (1980) 3.12
Transport of amino acids by confluent and nonconfluent 3T3 and polyoma virus-transformed 3T3 cells growing on glass cover slips. J Biol Chem (1969) 3.05
A binding site for sulfate and its relation to sulfate transport into Salmonella typhimurium. J Biol Chem (1966) 3.04
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 3.03
Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science (1986) 2.89
Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A (1993) 2.85
Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells. Cell (1979) 2.84
Purification and properties of a sulfate-binding protein from Salmonella typhimurium. J Biol Chem (1966) 2.69
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med (1996) 2.67
Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science (1996) 2.65
Conditional mutations involving septum formation in Escherichia coli. J Bacteriol (1967) 2.64
Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli. J Bacteriol (1968) 2.54
Thymidine and thymine incorporation into deoxyribonucleic acid: inhibition and repression by uridine of thymidine phosphorylase of Escherichia coli. J Bacteriol (1967) 2.41
Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses (2000) 2.37
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine. Nature (1986) 2.30
Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc Natl Acad Sci U S A (1979) 2.28
Sequence of enzyme synthesis and gene replication during the cell cycle of Bacillus subtilis. Proc Natl Acad Sci U S A (1965) 2.18
The Cronkhite-Canada Syndrome. An analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) (1982) 2.15
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol (1998) 2.12
Location of sulfate-binding protein in Salmonella typhimurium. J Bacteriol (1968) 2.11
Conditions for the selective synthesis of DNA complementary to template RNA. Biochim Biophys Acta (1973) 2.08
Regulation of sulfate transport in Salmonella typhimurium. J Bacteriol (1966) 2.06
A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry (1978) 2.05
Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cells. Proc Natl Acad Sci U S A (1979) 1.95
Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A (2000) 1.94
Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells. Proc Natl Acad Sci U S A (1982) 1.93
Evidence for a sulfate-binding site external to the cell membrane of Salmonella typhimurium. Biochim Biophys Acta (1965) 1.93
Cell-free activity of a sulfate binding site involved in active transport. Proc Natl Acad Sci U S A (1966) 1.92
Genetics of sulfate transport by Salmonella typhimurium. J Bacteriol (1971) 1.92
Deoxyribonucleic acid synthesis during the division cycle of Escherichia coli: a comparison of strains B-r, K-12, 15, and 15T- under conditions of slow growth. J Bacteriol (1974) 1.90
A biosynthetic ornithine decarboxylase in Escherichia coli. Biochem Biophys Res Commun (1965) 1.87
Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. J Virol (2006) 1.87
Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol (1987) 1.86
Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc Natl Acad Sci U S A (1982) 1.86
Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A (1998) 1.86
Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res (1994) 1.85
Cyclin E, a potential prognostic marker for breast cancer. Cancer Res (1994) 1.82
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res (2000) 1.80
Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell (1983) 1.76
Recent advances in differential display. Curr Opin Immunol (1995) 1.75
Cell division in Escherichia coli: evidence for regulation of septation by effector molecules. J Mol Biol (1972) 1.74
Fatty acid-requiring mutant of bacillus subtilis defective in branched chain alpha-keto acid dehydrogenase. J Biol Chem (1971) 1.73
Energy requirement for degradation of tumor-associated protein p53. Mol Cell Biol (1984) 1.73
Accumulation of a protein required for division during the cell cycle of Escherichia coli. J Bacteriol (1970) 1.71
Enzyme synthesis in synchronous cultures of bacteria. Biochem Biophys Res Commun (1964) 1.68
Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol (2000) 1.68
Loss of epidermal growth factor requirement and malignant transformation. Proc Natl Acad Sci U S A (1979) 1.65
Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys. J Immunol (1996) 1.65
Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1993) 1.64
Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells. J Cell Physiol (1984) 1.63
Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene (2000) 1.58
Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res (1993) 1.57
Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res (2001) 1.57
Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med (2000) 1.56
A general method for permeabilizing monolayer and suspension cultured animal cells. Exp Cell Res (1979) 1.56
Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol (1998) 1.52
Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol (1998) 1.52
Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem (2000) 1.50
Enhanced synthesis and stabilization of Mr 68,000 protein in transformed BALB/c-3T3 cells: candidate for restriction point control of cell growth. Proc Natl Acad Sci U S A (1983) 1.46
Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis. Proc Natl Acad Sci U S A (1988) 1.45
Cell-cycle-specific interaction of nuclear DNA-binding proteins with a CCAAT sequence from the human thymidine kinase gene. Proc Natl Acad Sci U S A (1987) 1.45
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A (2001) 1.44
Hyperproduction and purification of nicotinamide deamidase, a microconstitutive enzyme of Escherichia coli. J Biol Chem (1971) 1.41
Thymidine kinase transcription is regulated at G1/S phase by a complex that contains retinoblastoma-like protein and a cdc2 kinase. Proc Natl Acad Sci U S A (1992) 1.41
Requirement of polyamines for bacterial division. J Bacteriol (1970) 1.41
Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res (2000) 1.40
Determination of natural host taxonomy of RNA tumor viruses by molecular hybridization: application to RD-114, a candidate human virus. Proc Natl Acad Sci U S A (1973) 1.40
Prevalent deficiency in tumor cells of cycloheximide-induced cycle arrest. Proc Natl Acad Sci U S A (1980) 1.40
Inducible transport of citrate in a Gram-positive bacterium, Bacillus subtilis. J Biol Chem (1971) 1.39
Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Res (1989) 1.39
The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts. J Biol Chem (1985) 1.38
Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology (1999) 1.36
Animal cells: noncorrelation of length of G1 phase with size after mitosis. Science (1970) 1.35
Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. J Invest Dermatol (1999) 1.34
High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A (2001) 1.32
Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors. Blood (1997) 1.31